Article
Endocrinology & Metabolism
Eileen R. Faulds, Andrew Boutsicaris, Lyndsey Sumner, Laureen Jones, Molly McNett, Keaton S. Smetana, Casey C. May, Elizabeth Buschur, Matthew C. Exline, Matthew D. Ringel, Kathleen Dungan
Summary: This study provides data to support the feasibility, accuracy, safety, and potential workload reduction of using CGM with a hybrid protocol in the ICU for patients with COVID-19 on IV insulin therapy.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Endocrinology & Metabolism
Orianne Villard, Marc D. Breton, Swati Rao, Mary K. Voelmle, Morgan R. Fuller, Helen E. Myers, Ryan K. McFadden, Zander S. Luke, Christian A. Wakeman, Mary Clancy-Oliveri, Ananda Basu, Meaghan M. Stumpf
Summary: This study assessed the accuracy and clinical relevance of a factory-calibrated CGM in individuals on hemodialysis. The results showed that the CGM had reasonably accurate performance and is clinically relevant for improving diabetes management in this population.
Article
Obstetrics & Gynecology
Daria Di Filippo, Amanda Henry, Chloe Bell, Sarah Haynes, Melissa Han Yiin Chang, Justine Darling, Alec Welsh
Summary: This study aimed to evaluate the acceptability of Freestyle Libre Pro 2 as a diagnostic test for gestational diabetes mellitus (GDM), and to validate its results with OGTT and GDM risk factors. The results showed that CGM was a more acceptable alternative for GDM diagnosis. Triangulation analysis revealed both false positive and false negative results from OGTT screening.
BMC PREGNANCY AND CHILDBIRTH
(2023)
Article
Endocrinology & Metabolism
Charlene W. Lai, Terri H. Lipman, Steven M. Willi, Colin P. Hawkes
Summary: Racial/ethnic disparities exist in continuous glucose monitor (CGM) use among children with type 1 diabetes. The study found that lower CGM use in non-Hispanic Black children was due to lower rates of device initiation and higher rates of discontinuation. Interventions are needed to address both of these barriers in order to reduce disparities in CGM use.
Article
Endocrinology & Metabolism
Rosemary M. Hall, Sophie Dyhrberg, Arthur McTavish, Lindsay McTavish, Brian Corley, Jeremy D. Krebs
Summary: This study aimed to investigate the accuracy and acceptability of the FSL-CGM at alternative sites during free living and under experimental conditions. The results showed that the FSL-CGM is clinically accurate when the sensors are applied to alternate chest or back sites. However, there is greater variability during rapid changes in glucose concentration with all sensor sites compared with venous glucose.
DIABETES OBESITY & METABOLISM
(2022)
Article
Endocrinology & Metabolism
Andrew J. Karter, Melissa M. Parker, Howard H. Moffet, Lisa K. Gilliam, Richard Dlott
Summary: CGM may help prevent glycemic deterioration in well-controlled patients with insulin-treated T2D.
DIABETES TECHNOLOGY & THERAPEUTICS
(2022)
Article
Endocrinology & Metabolism
Charlene W. Lai, Terri H. Lipman, Steven M. Willi, Colin P. Hawkes
Summary: Racial-ethnic disparities in technology use, particularly in the initiation and sustained use of continuous glucose monitors (CGM), exist among children with type 1 diabetes (T1D), with non-Hispanic black (NHB) children having significantly lower rates of usage. Strategies to address these disparities should begin early in T1D management.
DIABETES TECHNOLOGY & THERAPEUTICS
(2021)
Article
Medical Laboratory Technology
Guido Freckmann, James H. Nichols, Rolf Hinzmann, David C. Klonoff, Yi Ju, Peter Diem, Konstantinos Makris, Robbert J. Slingerland
Summary: People with diabetes need to monitor their glucose levels regularly, and traditional self-monitoring systems are being replaced by minimally invasive continuous glucose monitoring systems. However, these CGM systems face challenges with accuracy and lack of international reference measurement procedures.
CLINICA CHIMICA ACTA
(2021)
Article
Endocrinology & Metabolism
Manuela Sinisterra, Christine H. Wang, Brynn E. Marks, John Barber, Carrie Tully, Maureen Monaghan, Marisa E. Hilliard, Randi Streisand
Summary: The study found that families with private insurance were more likely to use CGM, and CGM use patterns were associated with HbA1c levels in young children with T1D in the first 18 months post-diagnosis.
DIABETES TECHNOLOGY & THERAPEUTICS
(2021)
Editorial Material
Allergy
Michelle Xiong, Anne B. Neeley
Summary: This article reports a case of contact allergy to platinum which likely caused an adverse reaction to the Eversense E3 Continuous Glucose Monitor.
CONTACT DERMATITIS
(2022)
Article
Food Science & Technology
Khadidja Chekima, Benjamin Tziak Ze Wong, Mohd Ismail Noor, Yasmin Beng Houi Ooi, See Wan Yan, Brahim Chekima
Summary: This study found that parboiled basmati rice had positive effects on 24-hour glucose levels and variability among overweight and obese young adults. Preferences for rice varieties changed significantly with real-time continuous glucose monitoring.
Article
Endocrinology & Metabolism
Alexander Phu, Tyger Lin, Jacquelyn A. Manfredo, Elizabeth A. Brown, Risa M. Wolf
Summary: The objective of this study was to compare perceptions of continuous glucose monitoring (CGM) and quality of life (QoL) between patients with type 1 diabetes (T1D) and type 2 diabetes (T2D). Questionnaires were given to youth with T1D and T2D currently on insulin therapy, and the results showed that both groups had similar perspectives on CGM and QoL measures. This suggests that insulin use in both T1D and T2D may carry a similar burden of management, and CGM may help improve quality of life.
PEDIATRIC DIABETES
(2023)
Article
Endocrinology & Metabolism
Lauren A. Buehler, Vignesh Balasubramanian, Scott Baskerville, Ryan Bailey, Keira McCarthy, Marc Rippen, James F. Bena, Maria Cecilia Lansang
Summary: This study evaluated the performance of the Alertgy noninvasive continuous glucose monitor (ANICGM) in patients with type 2 diabetes and compared it with an approved glucose meter. The results showed that the MARD values of the ANICGM were stable, suggesting the potential for further research on the use of dielectric spectroscopy for glucose monitoring.
ENDOCRINE PRACTICE
(2022)
Article
Cell Biology
Ayya Keshet, Smadar Shilo, Anastasia Godneva, Yeela Talmor-Barkan, Yaron Aviv, Eran Segal, Hagai Rossman
Summary: Despite the increasing prevalence of diabetes, its diagnosis still relies on blood tests. Continuous glucose monitoring (CGM) devices provide a potential tool to better understand glucose control and variability in individuals with and without diabetes. This study presents CGMap, the characterization of CGM data collected from over 7,000 non-diabetic individuals, aged 40-70 years, between 2019 and 2022. The study provides reference values for key CGM-derived clinical measures and explores the relationship between CGM-derived measures and diabetes-related clinical parameters, revealing novel research directions for understanding the influence of glucose levels on various aspects of human health.
Article
Medical Laboratory Technology
Kriti Joshi, Mark Harris, Andrew Cotterill, John M. Wentworth, Jennifer J. Couper, Aveni Haynes, Elizabeth A. Davis, Kate E. Lomax, Tony Huynh
Summary: Type 1 diabetes (T1D) is a continuous process starting with the development of islet autoantibodies, progressing to beta cell destruction and eventually resulting in insulin deficiency and clinical disease. Early identification of pre-symptomatic individuals with T1D can help reduce the risk of diabetic ketoacidosis (DKA) and determine eligibility for prevention trials. Continuous glucose monitoring (CGM) is a valuable tool for detecting early glycaemic abnormalities and monitoring metabolic deterioration in at-risk individuals. This article explores the use of different diagnostic tests and advocates for an increased role of CGM in pre-symptomatic T1D.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
(2023)
